Skip to main content

Calorie Restrictions, Low-Fat Diets May Reduce Depressive Symptoms

Medically reviewed by Carmen Pope, BPharm. Last updated on May 20, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, May 19, 2025 -- Among adults with elevated cardiometabolic risk, calorie restrictions and low-fat diets may reduce depressive symptoms, according to a review published online May 20 in the Annals of Internal Medicine.

Eman Abukmail, M.D., from the Institute for Evidence Based Healthcare at Bond University in Gold Coast, Australia, and colleagues examined the effects of dietary interventions on depression and anxiety in a systematic review of randomized controlled trials. Data were included from 25 randomized controlled trials.

The researchers found that for adults with elevated cardiometabolic risk, depressive symptoms might be improved by dietary advice on calorie restriction compared with no specific dietary advice (standardized mean difference, −0.23; low-certainty). Small effects on depressive symptoms may be seen with low-fat diets among adults with elevated cardiometabolic risk (standardized mean difference, −0.03). Limited evidence was seen for other diets, comparing diets with active comparisons, and on anxiety.

"In conclusion, calorie restrictions and low-fat diets might reduce depressive symptoms among adults with elevated cardiometabolic risk, but the differences were small, and confidence in the findings was low," the authors write. "Evidence on other diets, comparisons to active interventions, and other outcomes is limited."

Abstract/Full Text (subscription or payment may be required

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Drop in Mental Health Scores Seen With Primary Open-Angle Glaucoma Diagnosis

MONDAY, June 9, 2025 -- Diagnosis of primary open-angle glaucoma (POAG) is associated with a reduction in mental health scores, according to a study published online June 5 in...

Dapagliflozin Beneficial for Improving MASH Without Worsening Fibrosis

FRIDAY, June 6, 2025 -- For patients with metabolic dysfunction-associated steatohepatitis (MASH), treatment with dapagliflozin is beneficial for improvement of MASH without...

Boarding Common for Pediatric Mental Health Emergency Department Visits

FRIDAY, June 6, 2025 -- One-third of pediatric mental health emergency department visits resulting in admission or transfer exceeded 12 hours, according to a study published in...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.